Wound Debridement Products Market Research Report- Forecast to 2027

Wound Debridement Products Market Research Report: By End-Users (Specialty Care, Nursing Units, Ambulatory Centers, Multi-Specialty Clinics and Hospitals) and By Region (Europe, Asia Pacific, Americas and the Middle East and Africa) – Forecast till 2027

ID: MRFR/MED/4174-HCR | March 2018 | Region: Global | 100 pages

Wound Debridement Products Market Analysis


Wound Debridement Products Market is anticipated to grow at a single-digit CAGR during the forecast period. Wound debridement is a process to eliminate foreign invaders, dead tissues, and toxic substances from human wounds. Wound debridement products aid in lowering poisonous materials that prevent wounds from getting healed. Growing aged population & serious wounds propel the wound debridement products market.


Moreover, widening product usage, chronic illnesses, & patient-base drive the industry. Cost-efficiency of wound products and demand for advanced medical facilities also contribute to industry growth. On the contrary, financial recession across some parts of the globe hampers the market. Awareness regarding injured tissues has urged patients to take debridement steps. The said factor has boosted industry revenues.


Manufacturers are developing a wide range of products, like scalpels and pads to treat minor wounds. Innovative plans are underway to entice customers into knowing more about these products. The worldwide industry is segmented into products, end-users, and geographies.


Wound Debridement Products Market Segment Insights


The products market will occupy more shares due to high adoption in homecare and hospitals. End-users include cardiac centers, multi-specialty clinics, hospitals, specialized clinics, nursing units, and ambulatory surgical wards. Hospitals are the biggest end-user and likely to capture the maximum shares by 2027. Specialized clinics and ambulatory surgical wards should observe “more than average” growth in the forecast period.


For businessmen and those investing in the wound debridement products market, hospitals are appealing & a bright opportunity. Regionally, the wound debridement market is split into Asia Pacific, Europe, Americas, and the Middle East and Africa. Americas, chased by Europe, accounts for the largest shares owing to higher advancements & medical expenditures. Apart from these factors, its burgeoning diabetics & geriatric base propel Americas.


Asia Pacific is reported to display huge growth in the coming years. Its growth would be attributed to the use of innovative products and need for improved medical technologies. Regional patient-base and expanding medical infrastructure can also contribute to its high CAGR. Moreover, expanding economies & demographics across emerging nations, like China and India are predicted to drive Asia Pacific.


Surge in the need for wound bed preparation and awareness on “timely wound care” advantages may provide novel prospects to the global market. In addition, the popularity of home-wound management and advancements in various technologies can broaden the scope of this industry. Mergers & acquisitions, need for lesser hospital stays, products innovations, and partnerships are some of the key trends that are being noticed.


Wound Debridement Products Market Key Players


Vital participants operating with the global wound debridement products industry are ArthoCare Corporation, Advanced Medical Solutions Group, Smith & Nephew Plc, and MediWound Ltd. The conventional market could register a decent absolute dollar prospect over the forecast period. The said fact will be ascribed to India and Africa’s huge population choosing conventional products due to their cost-efficiency.          


Cutting-Edge Products and Players


With depressing “wound mortality” news doing the rounds, researchers have been emphasizing the creation of smarter wound care products. These products intend to contain infections and treat injuries. “Axio Biosolutions,” a Bangalore-based Indian company is busy creating a new emergency wound hemostat. Lately, the firm also launched a dressing, namely “Axiostat.” It is gaining recognition in the defense forces and civil hospitals for combating traumatic bleeding.


A leading UK wound management firm recently got FDA approval for its innovative wound dressing, “KerraCel AG3+.” Another US based company, “Organogenesis” developed a product, “purple.”  It adopts antimicrobial PHMB and collagen as a protection that coupled with biofilm debridement prevents microbial growth and brings about a quick recovery. As described, the Wound Debridement Products Market is competitive, with numerous participants endeavoring to do better.



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant Value
  CAGR   2020-2027: Substantial CAGR
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Billion)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   End-Users and Region
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   ArthoCare Corporation, Advanced Medical Solutions Group, Smith & Nephew Plc, and MediWound Ltd.
  Key Market Opportunities   Expanding economies & demographics across emerging nations
  Key Market Drivers

  • Growing aged population & serious wounds propel market
  • Cost-efficiency of wound products and demand for advanced medical facilities


  • Speak to Analyst Ask for Customization